Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Antineoplastic agents>Tinib Antineoplastic drugs>Imatinib Impurity
Imatinib Impurity
  • Imatinib Impurity
  • Imatinib Impurity
  • Imatinib Impurity
  • Imatinib Impurity
  • Imatinib Impurity

Imatinib Impurity NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Imatinib Impurity CAS No.: 1076199-23-9
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31

Imatinib Impurity


Article illustration



  • Product No.:I003056

  • English Name:Imatinib Impurity 56

  • English Alias:tert-butyl 4-(4-((4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)carbamoyl)benzyl)piperazine-1-carboxylate

  • CAS No.:1076199-23-9

  • Molecular Formula:C₃₃H₃₇N₇O₃

  • Molecular Weight:579.69

  • Advantages

  • High-purity standard substance, suitable for impurity analysis, quality control, and methodology validation of Imatinib-related drugs. With a clear structure and good stability, it meets the strict requirements for qualitative and quantitative analysis of impurities in drug research, development, and production.

  • Applications

  • Mainly used for impurity research of Imatinib active pharmaceutical ingredients (APIs) and formulations, such as impurity limit detection, chromatographic method development and validation, and drug stability investigation. In the pharmaceutical industry, it can be used as a reference standard to evaluate the rationality of drug production processes, ensuring drug safety and quality controllability.

  • Background Description

  • Imatinib is a tyrosine kinase inhibitor widely used in the treatment of chronic myeloid leukemia (CML) and other diseases. The control of drug impurities is an important part of the drug quality system, as the presence of impurities may affect the efficacy and safety of drugs. As a related impurity of Imatinib, Imatinib Impurity 56 has a structure similar to the active ingredient. Therefore, the study of this impurity helps optimize the drug production process, reduce impurity content, and ensure drug quality.
  • Research Status

  • At present, research on Imatinib impurities mainly focuses on the synthesis, separation, characterization, and toxicity evaluation of impurities. Studies on Imatinib Impurity 56 are mostly combined with drug analysis techniques (such as HPLC, LC-MS, etc.) to establish impurity detection methods and formulate quality standards. With the improvement of drug regulatory requirements, the research on this impurity has gradually deepened, including its formation mechanism during drug storage and potential impact on drug efficacy. Relevant studies provide a scientific basis for the quality improvement and clinical application safety of Imatinib.
  • WhatsAPP: +86 17320513646
    E-mail: anna@molcoo.com


    NOTE!

    We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
    This product is intended for laboratory use only!

    WhatsAPP: +86 17320513646
    E-mail: anna@molcoo.com


    NEW IN STOCK!

    The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 





Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/25Kg/Bag
VIP5Y
Sinoway Industrial co., ltd.
2023-10-18
$999.00/10kg
VIP2Y
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
2024-08-08
$0.00/1kg
HangZhou RunYan Pharma Technology Co.,LTD.
2024-09-11
$0.00/1kg
VIP5Y
Sinoway Industrial co., ltd.
2025-03-27
$1.10/1g
VIP5Y
Dideu Industries Group Limited
2021-07-06
INQUIRY